Executive Voice: Taking a sharp look at cancer
Ron Lattanze, CEO of Lucerno Dynamics, has led the Morrisville-based company through a busy year.
The company is working to improve the quality of images produced by PET/CT scans through its Lara System device. It raised $6.3 million last year, listed the Lara System device with the U.S. Food and Drug Administration, and launched a 10,000-patient study.
The device detects and monitors infiltr ations in PET/CT scan radiotracer injections, which are designed to accumulate at areas of concern in theā¦
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Jennifer Henderson Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | CT Scan | Food and Drug Administration (FDA) | Health Management | PET Scan | Study